405 results
8-K
EX-99.1
jhzw 5m76
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
5qr0tm 7au
3 Apr 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:06pm
8-K
EX-4.7
ajed7n77t3
26 Feb 24
Other Events
5:08pm
8-K
EX-4.8
n9o ryjpqr5n
26 Feb 24
Other Events
5:08pm
8-K
EX-4.9
sbivvtjx7yzs brmyu
26 Feb 24
Other Events
5:08pm
8-K
EX-4.6
hwu1t
26 Feb 24
Other Events
5:08pm
8-K
EX-4.4
5erv exgau
26 Feb 24
Other Events
5:08pm
8-K
EX-4.2
m6z2cvayac3lj0
26 Feb 24
Other Events
5:08pm
8-K
EX-4.3
osttnl5 8h
26 Feb 24
Other Events
5:08pm
8-K
EX-4.5
xqjb ssz07v4kw
26 Feb 24
Other Events
5:08pm
424B5
n4rhf3qxir5suc hik78
26 Feb 24
Prospectus supplement for primary offering
6:12am
S-8
EX-4.4
syop3ibnv 71
22 Feb 24
Registration of securities for employees
5:50pm